Cullinan Therapeutics (CGEM) Competitors $11.60 +0.65 (+5.94%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends CGEM vs. BHC, ARWR, DYN, HCM, CPRX, AGIO, PTGX, IOVA, AMRX, and LBPHShould you be buying Cullinan Therapeutics stock or one of its competitors? The main competitors of Cullinan Therapeutics include Bausch Health Companies (BHC), Arrowhead Pharmaceuticals (ARWR), Dyne Therapeutics (DYN), HUTCHMED (HCM), Catalyst Pharmaceuticals (CPRX), Agios Pharmaceuticals (AGIO), Protagonist Therapeutics (PTGX), Iovance Biotherapeutics (IOVA), Amneal Pharmaceuticals (AMRX), and Longboard Pharmaceuticals (LBPH). These companies are all part of the "pharmaceutical products" industry. Cullinan Therapeutics vs. Bausch Health Companies Arrowhead Pharmaceuticals Dyne Therapeutics HUTCHMED Catalyst Pharmaceuticals Agios Pharmaceuticals Protagonist Therapeutics Iovance Biotherapeutics Amneal Pharmaceuticals Longboard Pharmaceuticals Cullinan Therapeutics (NASDAQ:CGEM) and Bausch Health Companies (NYSE:BHC) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, media sentiment, earnings, community ranking, dividends and institutional ownership. Is CGEM or BHC more profitable? Cullinan Therapeutics has a net margin of 0.00% compared to Bausch Health Companies' net margin of -1.88%. Cullinan Therapeutics' return on equity of -26.54% beat Bausch Health Companies' return on equity.Company Net Margins Return on Equity Return on Assets Cullinan TherapeuticsN/A -26.54% -25.32% Bausch Health Companies -1.88%-755.86%5.11% Which has more volatility and risk, CGEM or BHC? Cullinan Therapeutics has a beta of -0.18, meaning that its stock price is 118% less volatile than the S&P 500. Comparatively, Bausch Health Companies has a beta of 0.69, meaning that its stock price is 31% less volatile than the S&P 500. Which has better earnings & valuation, CGEM or BHC? Cullinan Therapeutics has higher earnings, but lower revenue than Bausch Health Companies. Bausch Health Companies is trading at a lower price-to-earnings ratio than Cullinan Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCullinan Therapeutics$18.94M35.66-$153.16M-$2.84-4.08Bausch Health Companies$9.47B0.29-$592M-$0.48-15.56 Does the MarketBeat Community believe in CGEM or BHC? Bausch Health Companies received 317 more outperform votes than Cullinan Therapeutics when rated by MarketBeat users. However, 82.35% of users gave Cullinan Therapeutics an outperform vote while only 61.47% of users gave Bausch Health Companies an outperform vote. CompanyUnderperformOutperformCullinan TherapeuticsOutperform Votes4282.35% Underperform Votes917.65%Bausch Health CompaniesOutperform Votes35961.47% Underperform Votes22538.53% Do analysts prefer CGEM or BHC? Cullinan Therapeutics presently has a consensus price target of $31.67, indicating a potential upside of 172.99%. Bausch Health Companies has a consensus price target of $7.75, indicating a potential upside of 3.75%. Given Cullinan Therapeutics' stronger consensus rating and higher probable upside, equities analysts plainly believe Cullinan Therapeutics is more favorable than Bausch Health Companies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cullinan Therapeutics 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00Bausch Health Companies 1 Sell rating(s) 5 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the media favor CGEM or BHC? In the previous week, Bausch Health Companies had 1 more articles in the media than Cullinan Therapeutics. MarketBeat recorded 11 mentions for Bausch Health Companies and 10 mentions for Cullinan Therapeutics. Bausch Health Companies' average media sentiment score of 0.97 beat Cullinan Therapeutics' score of 0.84 indicating that Bausch Health Companies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cullinan Therapeutics 6 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Bausch Health Companies 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders hold more shares of CGEM or BHC? 86.3% of Cullinan Therapeutics shares are held by institutional investors. Comparatively, 78.7% of Bausch Health Companies shares are held by institutional investors. 6.1% of Cullinan Therapeutics shares are held by company insiders. Comparatively, 8.1% of Bausch Health Companies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. SummaryCullinan Therapeutics beats Bausch Health Companies on 10 of the 18 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now Get Cullinan Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CGEM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CGEM vs. The Competition Export to ExcelMetricCullinan TherapeuticsBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$675.45M$2.94B$5.14B$9.08BDividend YieldN/A1.90%5.09%4.23%P/E Ratio-4.0846.7389.8217.18Price / Sales35.66415.011,116.21116.95Price / CashN/A182.1042.8937.86Price / Book1.093.894.784.78Net Income-$153.16M-$42.21M$120.23M$225.60M7 Day Performance-1.28%-2.15%-1.92%-1.23%1 Month Performance-5.07%4.20%11.49%3.36%1 Year Performance22.36%18.39%30.57%16.60% Cullinan Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CGEMCullinan Therapeutics1.8003 of 5 stars$11.60+5.9%$31.67+173.0%+32.7%$675.45M$18.94M-4.0830News CoverageBHCBausch Health Companies2.8422 of 5 stars$7.66-1.9%$7.75+1.2%+3.0%$2.77B$8.76B-16.2720,270Analyst RevisionARWRArrowhead Pharmaceuticals4.3674 of 5 stars$22.19+1.6%$42.70+92.4%-30.1%$2.76B$3.55M-4.35400Analyst ForecastInsider TradeNews CoverageDYNDyne Therapeutics3.1222 of 5 stars$26.05+1.2%$50.42+93.5%+104.9%$2.65BN/A-7.23100HCMHUTCHMED2.5894 of 5 stars$14.94-4.1%$19.00+27.2%-15.0%$2.60B$838M0.001,988Positive NewsCPRXCatalyst Pharmaceuticals4.6353 of 5 stars$21.78+1.9%$31.14+43.0%+48.7%$2.60B$398.20M18.12167Positive NewsAGIOAgios Pharmaceuticals4.2921 of 5 stars$44.19+13.4%$56.33+27.5%+53.6%$2.52B$32.87M3.73390Analyst ForecastPTGXProtagonist Therapeutics3.5882 of 5 stars$41.45+0.9%$53.78+29.7%+100.0%$2.47B$60M15.44125News CoveragePositive NewsIOVAIovance Biotherapeutics4.0084 of 5 stars$7.93+1.3%$22.33+181.6%+2.8%$2.42B$1.19M-5.25500AMRXAmneal Pharmaceuticals2.8853 of 5 stars$7.75-1.0%$10.00+29.0%+47.1%$2.40B$2.68B-11.387,700Analyst DowngradeNews CoverageLBPHLongboard Pharmaceuticals0.6628 of 5 stars$59.98+0.0%$59.56-0.7%+986.6%$2.34BN/A-26.9020 Related Companies and Tools Related Companies BHC Alternatives ARWR Alternatives DYN Alternatives HCM Alternatives CPRX Alternatives AGIO Alternatives PTGX Alternatives IOVA Alternatives AMRX Alternatives LBPH Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CGEM) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cullinan Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cullinan Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CGEM Stock Alerts